Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
69
RRC Quote, Financials, Valuation and Earnings
Last price:
$39.63
Seasonality move
:
19.85%
Day range:
$38.04 - $39.07
52-week range:
$27.29 - $41.95
Dividend yield:
0.85%
P/E ratio:
35.43x
P/S ratio:
4.03x
P/B ratio:
2.39x
Volume:
2M
Avg. volume:
2.9M
1-year change:
21.63%
Market cap:
$9.4B
Revenue:
$2.3B
EPS (TTM):
$1.10
Range Resources Number of Institutional Trades
Range Resources Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$5.5B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$10.3B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Range Resources Institutional Ownership
-
What Percentage Of RRC Is Owned by Institutions?
-- of RRC is owned by institutions.
-
How Many Institutions Own RRC Shares?
Range Resources stock is owned by 849 institutional shareholders at this time.
-
Have Institutions Been Buying RRC Stock?
Yes, institutions have bought 92.9M shares of RRC in the last quarter.
-
Have Institutions Been Selling RRC Stock?
Yes, institutions have sold 150.8M shares of RRC over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
